DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Brand Trends & Insights

Formerly known as BioTrends, we use our deep therapeutic expertise, layered onto data-driven insights, to support product success throughout the entire commercialization cycle.  We provide our customers with brand trends & insights by using brand-centric market research.  This research allows us to address not only the performance of brands and competitors in the marketplace, but also treatment decision drivers, including physician perception, awareness, and uptake.

Our innovative insights uncover the why, what, and how of brand performance

Evidence-based intelligence from the best informed disease experts

three 3-D arrows

Unmet Needs

Understanding crucial unmet needs and identifying opportunities in drug development with a focus on specific indications and insights into how well current or emerging therapies are poised to meet them.

Learn more
Blue spotlights shining in all directions

Commercial Targeting

Our solutions combine resolution physician network analysis with quantifiable payer and health system influence to identify the most influential physicians and institutions that are likely to have the highest impact on a community of practice.

Learn more

Pre-launch & New Product Planning

Our blend of clinical development experience, internal market planning tools, and therapeutic expertise uniquely positions our team to support the product development process.

Learn more

Most Recent Reports

Search Reports

Reports are available across 1000s of drug, treatment, and indication areas.

Advanced Search

Our latest thoughts and commentary

 

Latest articles

JAK inhibitors in IBD

On the Way to Becoming JAKs of All Trades On July 13th, 2017 Pfizer announced that its application for approval in ulcerative...

More Articles

In the news
News articles citing DRG analysts data.
More News